We are live on ! Find out more
BIOC

Biocept, Inc.
BIOC

Delisted

BIOC was delisted on the 24th of October, 2023.

Back to rankings

12 hedge funds and large institutions have $3.46M invested in Biocept, Inc. in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

315% more capital invested

Capital invested by funds: $832K → $3.46M (+$2.62M)

200% more funds holding

Funds holding: 4 → 12 (+8)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
12
Holders Change
+8
Holders Change %
+200%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
+$1.61M
2
SIM
Spark Investment Management
New York
+$537K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$470K
4
Bank of America
Bank of America
North Carolina
+$269K
5
CC
Callan Capital
California
+$67.2K

Top Sellers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
-$215K
2
PCM
Perkins Capital Management
Minnesota
-$134K
3
CP
Camelot Portfolios
Ohio
-$25K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Kennedy Capital Management
Missouri
$1.46M +$1.61M +24 New
SIM
2
Spark Investment Management
New York
$492K +$537K +8 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$482K +$470K +7 +700%
GBA
4
Garrison Bradford & Associates
New York
$301K – – –
Bank of America
5
Bank of America
North Carolina
$253K +$269K +4 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$74K +$67.2K +1 New
PCM
7
Perkins Capital Management
Minnesota
$69K -$134K -2 -67%
QIM
8
Quantitative Investment Management
Virginia
$68K +$67.2K +1 New
SCM
9
Sterneck Capital Management
Missouri
$53K +$67.2K +1 New
Northern Trust
10
Northern Trust
Illinois
$48K +$67.2K +1 New
TRCT
11
Tower Research Capital (TRC)
New York
$40K +$67.2K +1 New
CC
12
Callan Capital
California
$38K +$67.2K +1 New
Morgan Stanley
13
Morgan Stanley
New York
$27K – – –
Bank of Montreal
14
Bank of Montreal
Ontario, Canada
$22K – – –
William Blair & Company
15
William Blair & Company
Illinois
$22K – – –
Citigroup
16
Citigroup
New York
$4K – – –
MFS
17
MSI Financial Services
Massachusetts
$4K – – –
Creative Planning
18
Creative Planning
Kansas
$2K – – –
Verition Fund Management
19
Verition Fund Management
Connecticut
– -$215K -3 Closed
CP
20
Camelot Portfolios
Ohio
– -$25K – –

BIOC Hedge Fund Activity: Q1 2015 in Review

12 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2015, worth a combined $3.46M — up 315% from $832K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BIOC positions and 1 closed out — a net gain of 8 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $1.61M. The largest seller was Verition Fund Management, exiting entirely with an estimated $215K sold.

  • 12 institutional investors held Biocept, Inc. (BIOC) as of Q1 2015, up from 4 in Q4 2014.
  • Funds reported $3.46M of Biocept, Inc. stock for Q1 2015, up 315% quarter-over-quarter.
  • 9 funds opened new Biocept, Inc. positions in Q1 2015 and 1 closed out, a net change of +8 holders.
  • The largest Biocept, Inc. buyer in Q1 2015 was Kennedy Capital Management, an estimated $1.61M added.
  • The largest Biocept, Inc. seller in Q1 2015 was Verition Fund Management, an estimated $215K sold.

Based on aggregated 13F filings for Q1 2015.